Eric M Ruderman, MD
Eric Ruderman, MD, attended medical school at Albert Einstein College of Medicine from 1983-87 after graduating from Princeton University with a degree in English literature. He completed a residency in internal medicine at the Hospital of the University of Pennsylvania and a fellowship in rheumatology at Brigham and Women’s Hospital. His research work during his fellowship resulted in publications in Arthritis and Rheumatism and Journal of Infectious Diseases.
After fellowship, Dr Ruderman spent 6 years in private rheumatology practice before joining the faculty at Northwestern University, where he is currently a professor of medicine, clinical practice director for the rheumatology division, and co-director of a cooperative clinic for the management of psoriasis and psoriatic arthritis. In addition to his clinical roles, Dr Ruderman manages clinical trials in rheumatoid arthritis and other inflammatory arthritides, and serves as a vice-chair of Northwestern University’s institutional review board. As a consequence of his research interests, Dr Ruderman consults regularly on the development and utilization of rheumatologic therapeutics as well as chairing on the data safety monitoring boards for several industry and NIH sponsored trials.
Dr Ruderman is past president of the Chicago Rheumatism Society and serves on the board of the local chapter of the Arthritis Foundation. He is a past-chair of the Communications and Marketing Committee of the American College of Rheumatology. Dr Ruderman is on the editorial board of the Journal of Rheumatology. He has authored numerous book chapters and is co-editor of the textbook Psoriasis and Psoriatic Arthritis: An Integrated Approach.
Consultancy – AbbVie, Amgen, Eli Lilly, Genentech, Janssen, Novartis, Pfizer, Seattle Genetics; Research funding – Amgen, CORRONA, Pfizer